Standardized classification and reporting of glomerulonephritis.
Sethi S, Fervenza FC.
Nephrol Dial Transplant. 2019 Feb 1;34(2):193-199. doi: 10.1093/ndt/gfy220.
PMID:30124958
ANCA-Negative Pauci-immune Necrotizing Glomerulonephritis: A Case Series and a New Clinical Classification.
Ronsin C, Georges M, Chapelet-Debout A, Augusto JF, Audard V, Lebourg L, Rubin S, Quemeneur T, Bataille P, Karras A, Daugas E, Titeca-Beauport D, Boffa JJ, Vigneau C, Halimi JM, Isnard-Bagnis C, Durault S, Renaudineau E, Bridoux F, Testa A, Le Quintrec M, Renaudin K, Fakhouri F.
Am J Kidney Dis. 2022 Jan;79(1):56-68.e1. doi: 10.1053/j.ajkd.2021.03.027. Epub 2021 Jun 11.
PMID:34119564
Development of pauci-immune necrotizing glomerulonephritis during pembrolizumab treatment.
Pauci-Immune Necrotizing Glomerulonephritis as a Manifestation of Systemic Sclerosis Sine Scleroderma.
Shabaka A, Gatius S, Vian J, Pascual A, Rodriguez-Moreno A.
J Clin Rheumatol. 2021 Jan 1;27(1):e20-e21. doi: 10.1097/RHU.0000000000001208.
PMID:31789998
Necrotizing glomerulonephritis in patients with HIV, HCV and visceral leishmaniasis.
Puerta Carretero M, Ortega Díaz M, Corchete Prats E, Roldán Cortés D, Cuevas Tascón G, Martín Navarro JA, Jaldo Rodríguez MT, Medina Zahonero L, Cintra Cabrera M, Ryan Murúa P, Albalate Ramón M, de Sequera Ortiz P, Alcázar Arroyo R.
Effective management of necrotizing crescentic glomerulonephritis using an aggressive combination therapy including avacopan in a patient double-seropositive for anti-GBM antibodies and ANCA: a case report.
Tanaka R, Toishi T, Masaki R, Aihara H, Sakamoto S, Ikeda M, Inoue T, Kawaji A, Matsunami M, Fukuda J, Ohara M, Kuji H, Ichikawa D, Suzuki T.